Fundraising Fox

Aditya Kohli

Investor

Partner at Frazier Life Sciences

Palo Alto

About

Aditya Kohli is a Partner at Frazier Life Sciences focused on company creation, and has co-founded six companies since joining the firm in 2016, including HilleVax, Phathom Pharmaceuticals, and Scout Bio. He was Chief Business Officer of Phathom Pharmaceuticals (2019-2021) and Chief Operating Officer of HilleVax (2020-2024). Earlier he was an Engagement Manager at McKinsey & Company serving biopharmaceutical clients, and he holds a Ph.D. from the UC Berkeley-UCSF joint bioengineering program along with B.S. and M.Eng. degrees in biological engineering from MIT.

Invests in

Biotech

Experience

  1. Frazier Life SciencesPartnercurrent2025 β€” present
  2. Frazier Life SciencesVenture Partner2021 β€” 2025
  3. Frazier Life SciencesPrincipal2020 β€” 2021
  4. Frazier Life SciencesVice President2018 β€” 2019
  5. Frazier Life SciencesSenior Associate2016 β€” 2017
  6. HilleVaxBoard Director2021 β€” 2025
  7. HilleVaxCBO & Co-Founder2024
  8. HilleVaxCOO & Co-Founder2020 β€” 2024
  9. Scout BioBoard Director & Co-founder2019 β€” 2024
  10. Phathom PharmaceuticalsChief Business Officer & Co-founder2019 β€” 2021
  11. McKinsey & CompanyEngagement Manager2016New York
  12. McKinsey & CompanyAssociate2014 β€” 2016New York City Metropolitan Area

Education

  1. University of California, San FranciscoDoctor of Philosophy (Ph.D.), Bioengineering
  2. University of California, BerkeleyDoctor of Philosophy (Ph.D.), Bioengineering
  3. Massachusetts Institute of TechnologyB.S. / M.Eng., Bioengineering

Same school

Shared employers

Deals Β· 1

Scout Bio IncBoard seat

via Frazier Life Sciences Β· filed Apr 2019 Β· $20M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Frazier Life Sciences